Lameness improvement in horses with distal tarsal pain after intra-articular injection of botulinum neurotoxin type A.

The abstract presents a study that investigated the effectiveness of injecting botulinum toxin type A (BoNT-A) into horses with chronic osteoarthritis in the distal tarsal area. The researchers found that this treatment was successful in reducing lameness, particularly 90 days after injection.

Introduction to the Study

• The study aimed to evaluate the impact of intra-articular injections of botulinum toxin type A (BoNT-A) in horses suffering from chronic, naturally occurring osteoarthritis in the distal tarsal, an area within the horse’s hock or lower leg joint.
• The test subjects were horses with a specific kind of lameness known as impact lameness in a hindlimb. This answered positively to anesthetic blocks in the tarsometatarsal and centrodistal joints, both located in the lower rear leg.

Study Methodology

• The researchers used a randomized treatment assignment. Nine horses, selected based on physical and radiographic evaluations, received either an injection of BoNT-A or a saline solution as a placebo.
• The team tracked progress over post-injection days (PIDs) at several points for up to 180 days. They measured success by a decrease in impact lameness or an elimination of lameness in the affected limb, with the lameness shifting to the other limb.

Key Findings

• Five horses received the BoNT-A treatment, and four formed the placebo group. The BoNT-A group showed significant improvement in the measured periods, most notably at 90 to 180 days post-injection.
• Two out of the five horses that received BoNT-A treatment demonstrated a complete (100%) improvement in lameness at all the timepoints.
• Higher percentages of lameness improvement occurred at post-injection day 60.

Conclusion

• The research concludes that the intra-articular injection with 50 units of BoNT-A played a crucial role in reducing lameness in horses with distal tarsal osteoarthritis, especially noticeable 90 days after treatment.
• Botulinum toxin type A, therefore, is a potent tool that can be considered for managing horses with chronic osteoarthritis.